MedPath

Study which makes use of two different devices for placement of a tube to control breathing during anaesthesia

Phase 4
Recruiting
Conditions
Patients without any co-morbid conditions
Registration Number
CTRI/2018/03/012448
Lead Sponsor
Tejesh CA
Brief Summary

This is a randomized trial to compare the endotracheal intubation with the two videolaryngoscopes, King-vision and C-Mac, for endotracheal intubation in ASA class 1 & 2 adults aged 20-60 years undergoing surgery under general endotracheal anaesthesia. The primary outcome is the time taken for successful intubation with the two devices. The secondary outcomes are the glottic view, number of attempts at intubation, first-attempt success rate and proportion of successful intubation with the two devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
70
Inclusion Criteria

American Society of Anesthesiologists (ASA) Grade I and II Mallampatti grade I and II.

Exclusion Criteria

Mallampatti grade ≥ III BMI >30kg/m2 Thyromental distance <6cm Inter incisor distance <3cm Reduced neck extension Cervical spine instability Risk of pulmonary aspiration Pregnancy Oro-pharyngeal pathology Facial abnormalities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the time for successful intubation with King Vision and C-MAC videolaryngoscopes.At the end of endotracheal intubation following induction of general anaesthesia
Secondary Outcome Measures
NameTimeMethod
To compare theglottis view, number of attempts, first-attempt success rate and proportion of successful intubation with King Vision and C-MAC videolaryngoscopesAt end of endotracheal intubation following induction of general anaesthesia

Trial Locations

Locations (1)

MS Ramaiah Hospital

🇮🇳

Bangalore, KARNATAKA, India

MS Ramaiah Hospital
🇮🇳Bangalore, KARNATAKA, India
Kavya MS
Principal investigator
9035582232
ms.kavya2010@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.